Gene · 910
Papers2,023
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,023
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative immune responses to Mycobacterium tuberculosis in people with latent infection or sterilizing protection. | iScience | 2023 | 37564701 | PubTator, text mining | PubMed |
| L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab. | Cell Rep Med | 2023 | 37557179 | PubTator, text mining | PubMed |
| Interpretable Machine Learning of Amino Acid Patterns in Proteins: A Statistical Ensemble Approach. | J Chem Theory Comput | 2023 | 37552831 | PubTator, text mining | PubMed |
| Particulate matter impairs immune system function by up-regulating inflammatory pathways and decreasing pathogen response gene expression. | Sci Rep | 2023 | 37550362 | PubTator, text mining | PubMed |
| Exploration of novel clusters and prognostic value of immune‑related signatures and identify HAMP as hub gene in colorectal cancer. | Oncol Lett | 2023 | 37545621 | PubTator, text mining | PubMed |
| Clinical plasma cells-related genes to aid therapy in colon cancer. | BMC Genomics | 2023 | 37528394 | PubTator, text mining | PubMed |
| Usefulness of Docking and Molecular Dynamics in Selecting Tumor Neoantigens to Design Personalized Cancer Vaccines: A Proof of Concept. | Vaccines (Basel) | 2023 | 37514989 | PubTator, text mining | PubMed |
| Endogenous Opioids in Crohn's Disease. | Biomedicines | 2023 | 37509676 | PubTator, text mining | PubMed |
| The Roles of Exosomes in Ovarian Cancer Chemo-resistance. | J Cancer | 2023 | 37497408 | PubTator, text mining | PubMed |
| Control of porphyria cutanea tarda with anti-IL-17 secukinumab in a person with psoriasis living with HIV. | Oxf Med Case Reports | 2023 | 37484558 | PubTator, text mining | PubMed |
| Editorial: Hallmark of cancer: tumor promoting inflammation. | Front Oncol | 2023 | 37483513 | PubTator, text mining | PubMed |
| T-cell redirecting therapies for B-cell non-Hodgkin lymphoma: recent progress and future directions. | Front Oncol | 2023 | 37465110 | PubTator, text mining | PubMed |
| Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers. | Int J Mol Sci | 2023 | 37446025 | PubTator, text mining | PubMed |
| Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies. | Front Immunol | 2023 | 37441064 | PubTator, text mining | PubMed |
| Noncoding RNAs-based high KIF26B expression correlates with poor prognosis and tumor immune infiltration in colon cancer. | Cell Cycle | 2023 | 37436127 | PubTator, text mining | PubMed |
| Inflammatory and tolerogenic myeloid cells determine outcome following human allergen challenge. | J Exp Med | 2023 | 37428185 | PubTator, text mining | PubMed |
| Development of a circHIPK3-based ceRNA network and identification of mRNA signature in breast cancer patients harboring BRCA mutation. | PeerJ | 2023 | 37426414 | PubTator, text mining | PubMed |
| Transcriptome analysis of human macrophages upon chikungunya virus (CHIKV) infection reveals regulation of distinct signaling and metabolic pathways during the early and late stages of infection. | Heliyon | 2023 | 37408916 | PubTator, text mining | PubMed |
| Progranulin regulation of autophagy contributes to its chondroprotective effect in osteoarthritis. | Genes Dis | 2023 | 37397563 | PubTator, text mining | PubMed |
| CD1 and iNKT cells mediate immune responses against the GBS hemolytic lipid toxin induced by a non-toxic analog. | PLoS Pathog | 2023 | 37384812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/910/papers?page=6